A strong foundation in all key aspects of European post-marketing safety regulatory requirements, delivered in collaboration with the Dutch Medicines Evaluation Board (MEB).

The EFPIA Oncology Platform (EOP) and Lung Cancer Europe are hosting the first webinar in the EOP three-part series on National Cancer Control Plans (NCCPs) and cancer policy implementation in Europe, focusing on “Screening & Early Detection”.

Cluster ALISEI's flagship Life Sciences event returns to Rome, 13–14 October

Bringing together stakeholders from across the healthcare value chain, this HCI event will explore how Europe can strengthen medicines availability, improve coordination to address shortages, and build a more resilient healthcare system for patients.

Europe produces world-class cancer research, yet too often patients wait too long to benefit from scientific progress. Momentum 2026 is a new European high-level conference designed to help close that gap.

Organised by the EFPIA Cardiovascular Health Platform and IPHA, this event will explore how the EU Safe Hearts Plan can support the development and implementation of national cardiovascular health strategies across EU Member States.

The 2026 TOPRA Symposium will bring together regulatory affairs professionals and thought leaders from across the healthcare sector to discuss the latest developments and challenges shaping the regulatory landscape.

20 years of QPPVs talking to QPPVs. The DIA Global QPPV Forum — a trusted space for QPPVs, NCPs and PV professionals to exchange, get inspired, and connect

Join the Privacy Symposium conference to meet top level experts shedding light on the latest developments in data governance, regulatory compliance and innovative technologies.

What does it take for an oncology startup to stand out? Join Johnson & Johnson on 6 October for "Built to matter", a discussion on strategy, differentiation and what drives investment and partnership decisions.

Alzheimer’s is at a turning point in Europe. As new treatments emerge, the real challenge is no longer just innovation, but ensuring patients can access them in time.

This year’s Conference offers a wide variety of sessions for attendees, and will feature distinguished speakers from all around the world, relevant stakeholders and experts, to delve into the latest innovations in paediatrics.

How can we work collaboratively for Europe? Mastering interface and breaking silos between regulatory and HTA.

Taking place in Hong Kong this September, the event is also open to remote participants.

Join us on 7 September for the annual EFPIA Rentrée, marking the start of the new policy season.

From 24 to 26 June 2026, Cancer Patients Europe will host its Annual Meeting in Brussels, bringing together patient advocates, policymakers, healthcare stakeholders, and partners from across the cancer community.

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.

The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for Life Sciences Product Liability, Policy & Dispute Resolution.

The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”.  

This high-level briefing from the Financial Times, in partnership with Syneos Health, will bring together leading executives and investors to focus on what it takes to succeed in Europe’s launch environment.